Glia protect fetal midbrain dopamine neurons in culture from L-DOPA toxicity through multiple mechanisms

Journal of Neural Transmission

Volumn 104, Issue 4-5, 1997, Pages 317-328

  Mena, M A ^a   Casarejos, M J ^a   Carazo, A ^a   Paino C L ^a   Garcia De Yebenes J ^b  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

^b Fund Jiménez Díaz   (Spain)

Author keywords

Ascorbic acid; Dopamine neurons; Glia; Glutathione; L DOPA; Neurotrophic factors; Parkinson's disease

Indexed keywords

ANTIOXIDANT; ASCORBIC ACID; BRAIN DERIVED NEUROTROPHIC FACTOR; DOPAMINE; FREE RADICAL; GLUTATHIONE; LEVODOPA; NEUROTROPHIC FACTOR; QUINONE DERIVATIVE; SCAVENGER; TYROSINE 3 MONOOXYGENASE;

ANIMAL CELL; ARTICLE; CHEMICAL COMPOSITION; CONTROLLED STUDY; CULTURE MEDIUM; DOPAMINE UPTAKE; DOPAMINERGIC NERVE CELL; EMBRYO; GLIA; IMMUNOCOMPETENT CELL; MESENCEPHALON; MOLECULAR SIZE; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ANTIPARKINSON AGENTS; CELLS, CULTURED; CULTURE MEDIA; DOPAMINE; DOPAMINE AGENTS; FETUS; LEVODOPA; MESENCEPHALON; NEUROGLIA; NEURONS; NEUROPROTECTIVE AGENTS; RATS;

EID: 0030880246     PISSN: 03009564     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01277654     Document Type: Article

References (44)

1. Beart PM, McDonald D (1980) Neurochemical studies of the mesolimbic dopaminergic pathway: somatodendritic mechanisms and GABAergic neurons in rat ventral tegmentum. J Neurochem 34: 1622-1629
2. Blint J, Bonnet AM, Agid Y (1988) Does L-DOPA aggravate Parkinson's disease? Neurology 38: 1410-1416
3. Blunt SB, Jenner P, Marsden CD (1993) Suppressive effect of L-DOPA on dopamine cells remaining in the ventral tegmental area of rats previously exposed to the neurotoxin 6-hydroxydopamine. Mov Disord 8: 129-133
4. Bradford MM (1976) A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye-binding. Anal Biochem 72: 248-254
5. Damier P, Hirsch EC, Javoy-Agid F, Zhang P, Agid Y (1993) Protective role of glutathione peroxidase against neuronal death in Parkinson's disease. Neuroscience 52: 1-6
6. Engele J, Schubert D, Bohn MC (1991) Conditioned media derived from glial cell lines promote survival and differentiation of dopaminergic neurons in vitro: role of mesencephalic glia. J Neurosci Res 30: 359-371
7. Gall CM, Berschauer R, Isackson PJ (1994) Seizures increase basic fibroblast growth factor messenger mRNA in adult rat forebrain neurons and glia. Mol Brain Res 21: 190-205
8. Hefti F, Melamed E, Bhawan J, Wurtman RJ (1981) Long-term administration of L-DOPA does not damage dopaminergic neurons in the mouse. Neurology 31: 1194-1195
9. Hilwig I, Gropp A (1975) pH dependent fluorescence of DNA and RNA in cytologic staining with "33342 Hoechst". Exp Cell Res 91: 457-460
10. Hoffer BJ, Hofman A, Bowenkamp K, Huettl P, Hudson J, Martin D, Lin LFH, Gerhardt GA (1994) Glial cell line-derived neurotrophic factor reverses toxin-induced injury to midbrain dopaminergic neurons in vivo. Neurosci Lett 182: 107-111
11. Hyland K, Bottiglieri T (1992) Measurement of total plasma and cerobrospinal fluid homocysteine by fluorescence following high-performance liquid chromatography and precolumn derivatization with O-phthaldialdehyde. J Chromatogr 570: 55-62
12. Lesser RP, Fahn S, Snider SR, Cote LJ, Isgreen WP, Barret RE (1979) Analysis of the clinical problems in parkinsonisms and the complications of long-term L-DOPA therapy. Neurology 29: 1253-1260
13. Levison SW, McCarthy KD (1991) Astroglia in culture. In: Banker G, Goslin K (eds) Culturing nerve cells. The MIT Press, Cambridge, pp 309-336
14. Lin L-FH, Doherty DH, Lile JD, Bektosh S, Collins F (1993) GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science 260: 1130-1132
15. Makar TK, Nedergaard M, Preuss A, Gelbard AS, Perumal AS, Cooper AJ (1994) Vitamin E, ascorbate, glutathione, glutathione disulfide and enzimes of glutathione metabolism in cultures of chick astrocytes play an important role in antioxidative processes in the brain. J Neurochem 62: 45-53
16. Markham CH, Diamond SG (1986) Long term follow up of early DOPA treatment in Parkinson's disease. Ann Neurol 19: 365-372
17. Meister A (1988) Glutathione metabolism and its selective modification. J Biol Chem 263: 17205-17208
18. Melamed E (1986) Initiation of L-DOPA therapy in parkinsonian patients should be delayed until the advanced stages of the disease. Arch Neurol 43: 402-405
19. Mena MA, Pardo B, Casarejos MJ, Fahn S, G de Yebenes J (1992) Neurotoxicity of L-DOPA on catecholamine-rich neurons. Mov Disord 7: 441-445
20. Mena MA, Pardo B, Paino CL, G de Yebenes J (1993) L-DOPA toxicity in foetal rat midbrain neurones in culture: modulation by ascorbic acid. Neuro Report 4: 438-440
21. Mena MA, Casarejos MJ, Gimenez-Gallego G, G de Yebenes J (1995) Fibroblast growth factors: structure-activity on dopamine neurons in vivo. J Neural Transm 9: 1-14
22. Mena MA, Casarejos MJ, Paino CL, G de Yebenes J (1996) Glial conditioned medium protects fetal rat midbrain neurons in culture from L-DOPA toxicity. NeuroReport 7: 441-445
23. Muller HW, Junghans U, Kappler J (1995) Astroglial neurotrophic and neurite-promoting factors. Pharmacol Ther 65: 1-18
24. Mytilineou C, Han S, Cohen G (1993) Toxic and protective effects of L-DOPA on mesencephalic cell cultures. J Neurochem 61: 1470-1478
25. Nagata K, Takei N, Nakajima K, Saito H, Kohsaka S (1993) Microglial conditioned medium promotes survival and development of cultured mesencephalic neurons from embryonic rat brain. J Neurosci Res 34: 357-363
26. Nistico G, Ciriolo MR, Fiskin K, Iannone M, De Martino A, Rotillo G (1992) NGF restores decrease in catalase activity and increases superoxide dismutase and glutatione peroxidase activity in the brain of the aged rats. Free Radic Biol Med 12: 177-181
27. Pardo B, Mena MA, Casarejos MJ, Paino CL, de Yebenes JG (1995) Toxic effects of L-DOPA on mesencephalic cell cultures: protection with antioxidants. Brain Res 682: 133-143
28. Perry TL, Wee Yong V, Ito M, Foulks JG, Wall RA, Godin DV, Clavier RM (1984) Nigrostriatal dopamine neurons remain undamaged in rats given high doses of L-DOPA and carbidopa chronically. J Neurochem 43: 990-993
29. Quinn N, Parker D, Janota I, Marsden CD (1986) Preservation of the substantia nigra and locus coeruleus in a patient receiving L-DOPA (2 Kg) plus decarboxylase inhibitor over a four-year period. Mov Disord 1: 65-68
30. Raps SP, Lai J, Hertz I, Cooper AJL (1989) Glutahione is present in cultured astrocytes but not in cultured neurons. Brain Res 493: 398-401
31. Riederer P, Sofic E, Rausch WD, Schmidt B, Reynolds GP, Jellinger K, Youdim MBH (1989) Transition metals, ferritin, glutahione, and ascorbic acid in parkinsonian brains. J Neurochem 52: 515-520
32. Sagara J, Miura K, Bannai S (1993) Maintenance of neuronal glutathione by glial cell. J Neurochem 61: 1672-1676
33. Sagara J, Makino N, Bannai S (1996) Glutathione efflux from cultured astrocytes. J Neurochem 66: 1876-1881
34. Sian J, Dexter DT, Lees AJ, Daniel SE, Agid Y, Javoy-Agid F, Jenner P, Marsden CD (1994) Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia. Ann Neurol 36: 348-355
35. Siushansian R, Dixon SJ, Wilson JX (1996) Osmotic swelling stimulates ascorbate efflux from cerebral astrocytes. J Neurochem 66: 1227-1223
36. Slivka A, Mytilineou C, Cohen G (1987) Histochemical evaluation of glutahione in brain. Brain Res 409: 275-284
37. Spranger M, Lindholm D, Bandtlow C, Heuman R, Gnahn H, Naher Noe M, Thoenen H (1990) Regulation of nerve growth factor (NGF) synthesis in rat central nervous system: comparison between the effects of interleukin-1 and various growth factors in astrocyte culture and in vivo. Eur J Neurosci 2: 69-76
38. Takeshima T, Shimoda K, Sauve Y, Commissiong JW (1994a) Astrocyte-dependent and independent phases of the development and survival of rat embryonic day 14 mesencephalic neurons in culture. Neuroscience 60: 809-823
39. Takeshima T, Johnston JM, Commissiong JW (1994b) Oligodendrocyte-type-2 astrocyte (O-2A) progenitors increase the survival of rat mesencephalic dopaminergic neurons from death induced by serum deprivation. Neurosci Lett 166: 178-182
40. Thomas SA, Matsumoto AM, Palmiter RD (1995) Noradrenaline is essential for mouse fetal development. Nature 374: 643-646
41. Uitti RJ, Ahlskog JE, Maraganore DM, Muentner MD, Atkinson EJ, Cha RH, O'Brien PC (1993) L-DOPA therapy and survival in idiopathic Parkinson's disease: Olmsted County Project. Neurology 43: 1918-1926
42. Washko PW, Hartzell WO, Levine M (1989) Ascorbic acid analysis using high-performance liquid chromatography with coulometric electrochemical detection. Anal Biochem 181: 276-282
43. Yurek DM, Steece-Collier K, Collier TJ, Sladek JR (1991) Chronic L-DOPA impairs the recovery of dopamine agonist-induced rotational behavior following neural grafting. Exp Brain Res 86: 97-107
44. Zhou QY, Quaife CJ, Palmiter RD (1995) Target disruption of the tyrosine hydroxylase gene reveals that catecholamines are required for mouse fetal development. Nature 374: 640-643